Phychem Technologies IPO Final Day: GMP ₹0
Alright folks, it’s the final bell for Phychem Technologies’ SME IPO on the BSE, and as we wrap up Day 3, the subscription numbers are… well, let’s just say they’re still developing. With the IPO period closing today, August 2nd, 2026, investors have had their chance to weigh in. The issue price is set at a neat ₹54 per share, and the lot size is 2000 shares. Let’s dive into what the closing day is telling us.
Subscription Status
As of the closing hours on Day 3, the subscription figures for Phychem Technologies’ IPO are showing 0x across all categories: Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). This is a rather unusual situation for an SME IPO on its closing day. Typically, by the final day, we’d expect to see some traction, especially in the retail segment. The fact that all categories are at 0x subscription is quite telling. For retail investors, this usually means a lack of interest or perhaps a wait-and-see approach that didn’t materialize. For NII and QIBs, it could indicate they’re not finding the valuation compelling enough or have other, more attractive opportunities. The total subscription also stands at 0x, which is quite unprecedented and suggests that the IPO might not get fully subscribed. This could concern investors who are looking for strong demand signals.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 4.31x | |
| Total | 4.31x |
GMP Update
Now, let’s talk Grey Market Premium (GMP). The current GMP for Phychem Technologies IPO is ₹0. Yesterday, it was also at ₹0, so there’s been no change. A GMP of ₹0 means that the market isn’t currently pricing in any listing gains. The expected listing price, based on the issue price of ₹54 and a GMP of ₹0, is indeed ₹54. This is neither encouraging nor concerning from a GMP perspective, as it simply reflects a neutral market sentiment. However, coupled with the zero subscription numbers, it paints a picture of very subdued investor interest. We’ll need to see if any last-minute subscriptions come in, but as it stands, the GMP isn’t providing any positive buzz.
Should You Apply?
So, the big question: should you have applied for Phychem Technologies IPO? Based on the data available today, the subscription numbers are extremely low, and the GMP is at zero. This suggests a significant lack of investor appetite. While SME IPOs can sometimes see a surge in the final hours, the absence of any subscriptions by the closing day is a red flag. The SEBI advisor’s role here is to ensure fair practices, and for investors, it’s about making informed decisions based on market signals. The current scenario indicates that the market is not enthusiastically embracing Phychem Technologies at its issue price. If you were considering applying, this lack of demand and neutral GMP would likely make you pause. It’s always wise to consult with a registered financial advisor before making any investment decisions, especially in the SME segment where volatility can be higher. For now, it looks like a rather quiet end to the Phychem Technologies IPO subscription period.